Product Details for NDA 020234
TEGRETOL-XR (CARBAMAZEPINE)
100MG
Marketing Status: Prescription
200MG
Marketing Status: Prescription
400MG
Marketing Status: Prescription
100MG
Marketing Status: Prescription
Active Ingredient: CARBAMAZEPINE
Proprietary Name: TEGRETOL-XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020234
Product Number: 001
Approval Date: Mar 25, 1996
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
TEGRETOL-XR (CARBAMAZEPINE)
Proprietary Name: TEGRETOL-XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020234
Product Number: 001
Approval Date: Mar 25, 1996
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
200MG
Marketing Status: Prescription
Active Ingredient: CARBAMAZEPINE
Proprietary Name: TEGRETOL-XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020234
Product Number: 002
Approval Date: Mar 25, 1996
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
TEGRETOL-XR (CARBAMAZEPINE)
Proprietary Name: TEGRETOL-XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020234
Product Number: 002
Approval Date: Mar 25, 1996
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
400MG
Marketing Status: Prescription
Active Ingredient: CARBAMAZEPINE
Proprietary Name: TEGRETOL-XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 400MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020234
Product Number: 003
Approval Date: Mar 25, 1996
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: TEGRETOL-XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 400MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020234
Product Number: 003
Approval Date: Mar 25, 1996
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status: Prescription
Patent and Exclusivity Information